← Back to Clinical Trials
Recruiting NCT07317323

Norwegian Spontaneous Coronary Artery Dissection Study

Trial Parameters

Condition SCAD
Sponsor Oslo University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-04-01
Completion 2035-12-31

Brief Summary

The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospitalized with SCAD are recruited during the index hospitalization. Each participant will be followed for 52 weeks with scheduled visits at 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac assessments, genetic analyses, blood sampling, structured questionnaires, and a cardiopulmonary exercise test (CPET).

Eligibility Criteria

Inclusion Criteria: * Spontaneous coronary artery dissection Exclusion Criteria: * Severe kidney failure * Severe allergic reaction to contrast

Related Trials